Aptamino

New York, United States

Aptamino is a biotechnology company that enables oral antibody delivery utilizing protein design.

$8.0M raised

Apr 2026

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aptamino

How much funding has Aptamino raised?

Aptamino has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.

Where is Aptamino headquartered?

Aptamino is headquartered in New York, United States.

What does Aptamino do?

Aptamino is a biotechnology company that enables oral antibody delivery utilizing protein design.

What stage is Aptamino at?

Aptamino is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 3, 2026.

MLA

"Aptamino — Funding & Investors." VCBacked, April 3, 2026, https://www.vcbacked.co/company/aptamino. Accessed July 2, 2026.

APA

VCBacked. (2026). Aptamino — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aptamino

Wikipedia (cite web)

{{cite web |title=Aptamino — Funding & Investors |url=https://www.vcbacked.co/company/aptamino |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 3, 2026.